Neurocrine Bioscience buy Wedbush
Start price
13.09.23
/
50%
€107.25
Target price
13.09.24
€127.63
Performance (%)
3.78%
Price
28.08.24
€111.30
Summary
This prediction is currently active. With a performance of 3.78%, the BUY prediction by Wedbush for Neurocrine Bioscience is trending in the right direction. This prediction currently runs until 13.09.24. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | -17.708% | -17.708% |
iShares Core DAX® | 1.743% | 1.903% |
iShares Nasdaq 100 | -2.088% | -0.640% |
iShares Nikkei 225® | 1.306% | 4.161% |
iShares S&P 500 | -0.093% | 0.169% |
Comments by Wedbush for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Wedbush from $120.00 to $137.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Wedbush for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.80
29.05.24
29.05.24
€140.10
29.05.25
29.05.25
-10.10%
28.08.24
28.08.24